Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01152294 · ClinicalTrials.gov registry record · NA
Measuring Quality of Decisions About Treatment of Menopausal Symptoms
A NA study, sponsored by University of Massachusetts, Boston.
- Completed
- Registry status
- NA
- Development phase
- 401
- Enrollment target
NCT01152294: Completed NA study, sponsored by University of Massachusetts, Boston.
NCT01152294 is a NA study that has completed, run by University of Massachusetts, Boston. The registered enrollment target is 401 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01152294, a NA study, has completed, sponsored by University of Massachusetts, Boston.
- COMPLETED
- Registry status
- NA
- Development phase
- 401 participants
- Enrollment target
Study Summary
The purpose of this randomized controlled trial is to examine the impact of a patient decision aid on the quality of decisions about managing symptoms of menopause. In particular, we will examine whether the decision aid increases knowledge about menopause/managing menopause symptoms and concordance between goals and treatment choices.
Primary Outcome
Total knowledge score from factual questions about menopause and methods for managing menopause symptoms. Score is the percent of knowledge questions answered correctly (0 - 100%)
Interventions
- BEHAVIORAL DVD & Booklet called: Managing Menopause
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 401 participants |
| Start Date | 2010-06 |
| Est. Completion | 2010-11 |
| Phase | NA |
What the finished NCT01152294 record still lists
NCT01152294 is an interventional study that assigns participants to a tested intervention. The registered 401 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 1 intervention - of which DVD & Booklet called: Managing Menopause is the first listed.
NCT01152294 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01152294 about?
NCT01152294 is a clinical study titled "Measuring Quality of Decisions About Treatment of Menopausal Symptoms". The purpose of this randomized controlled trial is to examine the impact of a patient decision aid on the quality of decisions about managing symptoms of menopause. In particular, we will examine whether the decision aid increases knowledge about menopause/managing menopause symptoms and concordance...
What is the current status of trial NCT01152294?
This trial is currently completed. It is a NA study. The enrollment target is 401 participants. The study started on 2010-06. Estimated completion is 2010-11.
What interventions are being tested in trial NCT01152294?
The interventions under investigation include: DVD & Booklet called: Managing Menopause (BEHAVIORAL).
Who is sponsoring clinical trial NCT01152294?
This trial is sponsored by University of Massachusetts, Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01152294's enrollment target sits among peer trials
401 246th of 2000 higher than 1,755 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04464226 · 402 participants · Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
- NCT05183763 · 402 participants · NA
Medication Adherence Program
- NCT06748222 · 402 participants · Phase 3
E-Mindfulness Approaches for Living After Breast Cancer
- NCT06896474 · 402 participants · NA
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia